Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Weiss

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Plos One|April 5, 2022
Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodoneScott G Weiner, Michelle A Hendricks, Sanae El Ibrahimi, et al.
JAMA Network Open|January 28, 2022
Factors Associated With Opioid Overdose After an Initial Opioid PrescriptionScott G Weiner, Sanae El Ibrahimi, Michelle A Hendricks, et al.
The Journal of Clinical Psychiatry|May 25, 2010
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trialTheresa M Winhusen, Eugene C Somoza, Gregory S Brigham, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BDNaomi M Simon, Michael W Otto, Roger D Weiss, et al.
Drug and Alcohol Dependence|November 5, 2019
Craving and opioid use disorder: A scoping reviewBethea A Kleykamp, Marta De Santis, Robert H Dworkin, et al.
JAMA Internal Medicine|July 18, 2017
Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical TrialJane M Liebschutz, Ziming Xuan, Christopher W Shanahan, et al.
The American Journal on Addictions|April 6, 2006
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participantsMark D Fossey, Michael W Otto, William R Yates, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Plos One|April 5, 2022
Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodoneScott G Weiner, Michelle A Hendricks, Sanae El Ibrahimi, et al.
JAMA Network Open|January 28, 2022
Factors Associated With Opioid Overdose After an Initial Opioid PrescriptionScott G Weiner, Sanae El Ibrahimi, Michelle A Hendricks, et al.
The Journal of Clinical Psychiatry|May 25, 2010
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trialTheresa M Winhusen, Eugene C Somoza, Gregory S Brigham, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BDNaomi M Simon, Michael W Otto, Roger D Weiss, et al.
Drug and Alcohol Dependence|November 5, 2019
Craving and opioid use disorder: A scoping reviewBethea A Kleykamp, Marta De Santis, Robert H Dworkin, et al.
JAMA Internal Medicine|July 18, 2017
Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical TrialJane M Liebschutz, Ziming Xuan, Christopher W Shanahan, et al.
The American Journal on Addictions|April 6, 2006
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participantsMark D Fossey, Michael W Otto, William R Yates, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
Pageof 28